Here's a recap of recent blog posts and other news.
Doy think you or someone you love are on too many meds?
Did you know that reducing your medication burden may be the single best thing you can do to
improve your quality of life?
Adverse drug events are now a leading cause of hospitalization, disability, and death, all at great human and financial cost. Seniors are particularly vulnerable, as aging affects our ability to process medications and our resistance to adverse effects. Seniors are likely to be on multiple medications for various chronic conditions, putting them most at risk. More than 40% of US adults age 65 and over take five or more prescription medications.
Introducing TaperMD
TaperMD is a revolutionary solution to the problems of managing multiple medications in older adults.
Developed with McMaster University,
we built it to help patients, doctors, and pharmacists work as a team to address the serious problems of polypharmacy and drug side effects, and to fit in with normal consultation processes and flow. It is currently in clinical trials in Canada and Australia.
Call for Beta testers
We are looking for Beta testers -- with an initial focus on North America (but please apply if you are in another country so we can determine which markets to work with next): TaperMD.com/beta-trial.
There are a limited number of Beta spots available. We hope to engage with testers in the following groups to improve TaperMD for each group:
- Primary care physicians and nurse practitioners.
- Geriatricians.
- Pharmacists.
- Hospitals.
- Long-term care facilities.
- Payers (government, insurance companies, corporations).
- Pharmacy chains.
- Patient advocate groups.
There will be a nominal fee to participate in the Beta test, plus fees for any customization or specialized training.
Download our Pause and Monitor white paper
If you are a patient who is concerned about your medication burden, let your doctor know about TaperMD and the white paper, which can be downloaded at TaperMD.com/learn-more.
Thank you for your support.
Your feedback, as always, is greatly appreciated.
Dee Mangin, MD
|
